Mobile Menu

Press Room

British Dragon Pharma is a pioneer and world leader in the development, manufacturer and marketing of controlled-release pharmaceutical products. British Dragon's shares are listed on the New York (NYSE) and Toronto Stock Exchange (TSX).

The British Dragon Press Room features the latest press releases and scientific and financial news on the company and its products, as well as a select archive of press releases and related materials.

Transmucosal Insulin Administration
Transmucosal Insulin Administration

British Dragon Pharma announced today that it presented pre-clinical data suggesting its transmucosal insulin can deliver significant dosages of insulin into the bloodstream

Significant Testabol Propionate Phase II Efficacy Results
Significant Testabol Propionate Phase II Efficacy Results

British Dragon Pharma announced new Testabol Propionate (bioidentical testosterone propionate) Phase II clinical trial efficacy data will be presented today at the annual meeting of the American Society for Reproductive Medicine (ASRM) in Philadelphia.

1 2 ›
)

Customer Reviews

Please leave your review on products or service below.
Thank you beforehand.

Write a Review View Reviews

Add to Cart - Product(s)

Close Button
Empty

Total Cost:

To order products from us, you have to be at least 21 years of age. British-Dragon.org takes no responsibility for confirming the importation requirements and regulations of the purchase and the purchaser's country of origin. All products are shipped at the full risk of the purchaser in agreement of our site reserved towards any legal action that might be brought against the purchaser if not acting in accordance with the regulations and importation laws of the destination country.